The linker histone H1fx is the least characterized member of the H1 family. To investigate the developmental changes of H1fx, we performed an immunohistochemical analysis of its expression pattern from embryos to adult mice. We found that H1fx was highly expressed during gastrulation, and was positive in all embryonic germ layers between E8.5 and E10.5, which mostly overlapped with the expression of the proliferation marker Ki-67. Neural and mesenchyme tissues strongly expressed H1fx at E10.5. H1fx expression began to be restricted at around E12.5. Western blot analysis of brain tissues demonstrated that the total expression level of H1fx gradually decreased with time from E12.5 to adulthood, whereas H1f0 was increased over this period. In adult mice, H1fx was restrictively expressed at the hypothalamus, subventricular zone, subgranular zone, medulla of the adrenal grand, islets of Langerhans, and myenteric plexus. Taken together, these data suggest that H1fx is preferentially expressed in immature embryonic cells and plays some roles in cells with neural properties.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5582669 | PMC |
| http://dx.doi.org/10.1369/0022155417723914 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Single-cell RNA sequencing reveals multiple immune cell subpopulations promote the formation of abnormal bone microenvironment in osteoporosis.
Sci Rep
November 2024
Department of Orthopedics, The Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, 545005, Guangxi, People's Republic of China.
Article Synopsis
- The increasing incidence of osteoporosis (OP) with an aging population highlights the need to understand immune cell subpopulations that contribute to the disease, which are currently not well understood.
- Bioinformatics analysis was used to map the OP microenvironment, revealing specific immune cell subpopulations—including macrophages, neutrophils, effector memory T cells, and B cells—that play roles in abnormal bone conditions and potentially serve as therapeutic targets.
- Identified cell subpopulations showed activation of pathways related to cytokines and osteoclast differentiation, suggesting that immune inflammation responses may drive osteoporosis, providing insights for future research and treatment possibilities.
LINC00887 Acts as an Enhancer RNA to Promote Medullary Thyroid Carcinoma Progression by Binding with FOXQ1.
Curr Cancer Drug Targets
May 2024
Department of Otolaryngology & Head and Neck Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050035, China.
Background: Medullary thyroid carcinoma (MTC) is a rare but aggressive endocrine malignancy that originates from the parafollicular C cells of the thyroid gland. Enhancer RNAs (eRNAs) are non-coding RNAs transcribed from enhancer regions, which are critical regulators of tumorigenesis. However, the roles and regulatory mechanisms of eRNAs in MTC remain poorly understood.
View Article and Find Full Text PDFDownregulation of HINFP induces senescence-associated secretory phenotype to promote metastasis in a non-cell-autonomous manner in bladder cancer.
Oncogene
July 2022
State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
Article Synopsis
- Transcription dysregulation plays a significant role in bladder cancer, with a specific focus on the downregulation of the histone H4 transcription factor (HINFP), which is linked to poorer patient outcomes.
- Inhibition of HINFP leads to DNA damage and cell senescence, resulting in reduced growth of bladder cancer cells; however, senescent cells release factors that can promote the invasion of non-senescent cells.
- Histone deacetylase inhibitors (HDACis) can eliminate these senescent cells and may offer a therapeutic advantage for bladder cancer patients dealing with metastasis related to cell senescence.
A Prognostic Model Based on Immune-Related Long Non-Coding RNAs for Patients With Cervical Cancer.
Front Pharmacol
November 2020
Medical Oncology Department, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangdong, China.
The study is performed to analyze the relationship between immune-related long non-coding RNAs (lncRNAs) and the prognosis of cervical cancer patients. We constructed a prognostic model and explored the immune characteristics of different risk groups. We downloaded the gene expression profiles and clinical data of 227 patients from The Cancer Genome Atlas database and extracted immune-related lncRNAs.
View Article and Find Full Text PDFA newly identified lncRNA H1FX-AS1 targets DACT1 to inhibit cervical cancer via sponging miR-324-3p.
Cancer Cell Int
July 2020
Department of Obstetrics and Gynecology, the Second Affiliated Hospital of Soochow University, No. 1055 Sanxiang Road, Suzhou, 215000 China.
Background: Cervical cancer (CC) is the 4th most common cancer-related death in gynecological cancer worldwide. It has been reported that many lncRNAs contribute to oncogenesis although the fundamental mechanisms are basically unknown. Here, we aimed to identify a novel lncRNA H1FX-AS1 and explore a ceRNA network in CC oncogenesis and progression.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!